1. Maintenance and functional regulation of immune memory to COVID-19 vaccines in tissues.
- Author
-
Davis-Porada J, George AB, Lam N, Caron DP, Gray JI, Huang J, Hwu J, Wells SB, Matsumoto R, Kubota M, Lee Y, Morrison-Colvin R, Jensen IJ, Ural BB, Shaabani N, Weiskopf D, Grifoni A, Sette A, Szabo PA, Teijaro JR, Sims PA, and Farber DL
- Subjects
- Humans, Aged, Middle Aged, Adult, Aged, 80 and over, Female, Male, Lung immunology, Lung virology, Young Adult, Spike Glycoprotein, Coronavirus immunology, B-Lymphocytes immunology, Lymphoid Tissue immunology, Vaccination, Immunologic Memory immunology, SARS-CoV-2 immunology, COVID-19 immunology, COVID-19 prevention & control, Memory T Cells immunology, COVID-19 Vaccines immunology
- Abstract
Memory T and B cells in tissues are essential for protective immunity. Here, we performed a comprehensive analysis of the tissue distribution, phenotype, durability, and transcriptional profile of COVID-19 mRNA vaccine-induced immune memory across blood, lymphoid organs, and lungs obtained from 63 vaccinated organ donors aged 23-86, some of whom experienced SARS-CoV-2 infection. Spike (S)-reactive memory T cells were detected in lymphoid organs and lungs and variably expressed tissue-resident markers based on infection history, and S-reactive B cells comprised class-switched memory cells resident in lymphoid organs. Compared with blood, S-reactive tissue memory T cells persisted for longer times post-vaccination and were more prevalent with age. S-reactive T cells displayed site-specific subset compositions and functions: regulatory cell profiles were enriched in tissues, while effector and cytolytic profiles were more abundant in circulation. Our findings reveal functional compartmentalization of vaccine-induced T cell memory where surveilling effectors and in situ regulatory responses confer protection with minimal tissue damage., Competing Interests: Declaration of interests A.S. is a consultant for Gritstone Bio, Flow Pharma, Moderna, AstraZeneca, Qiagen, Fortress, Gilead, Sanofi, Merck, RiverVest, MedaCorp, Turnstone, NA Vaccine Institute, Emervax, Gerson Lehrman Group, and Guggenheim. La Jolla Institute. has filed for patent protection for various aspects of T cell epitope and vaccine design work. Columbia University has filed patent applications related to vaccine tissue assays., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF